化学
髓系白血病
喹啉
激酶
IC50型
细胞培养
白血病
细胞生长
体内
部分
体外
立体化学
癌症研究
生物化学
药理学
生物
免疫学
有机化学
生物技术
遗传学
作者
Neetu Dayal,Eva Řezníčková,Delmis E. Hernandez,Miroslav Peřina,Sandra E Torregrosa‐Allen,Bennett D. Elzey,Jana Škerlová,Haresh Ajani,Stefan Djukic,Veronika Vojáčková,Martin Lepšı́k,Pavlína Řezáčová,Vladimı́r Kryštof,Radek Jorda,Herman O. Sintim
标识
DOI:10.1021/acs.jmedchem.1c00330
摘要
The 3 H -pyrazolo[4,3- f ]quinoline moiety has been recently shown to be a privileged kinase inhibitor core with potent activities against acute myeloid leukemia (AML) cell lines in vitro. Herein, various 3 H -pyrazolo[4,3- f ]quinoline-containing compounds were rapidly assembled via the Doebner–Povarov multicomponent reaction from the readily available 5-aminoindazole, ketones, and heteroaromatic aldehydes in good yields. The most active compounds potently inhibit the recombinant FLT3 kinase and its mutant forms with nanomolar IC 50 values. Docking studies with the FLT3 kinase showed a type I binding mode, where the 3 H -pyrazolo group interacts with Cys694 in the hinge region. The compounds blocked the proliferation of AML cell lines harboring oncogenic FLT3-ITD mutations with remarkable IC 50 values, which were comparable to the approved FLT3 inhibitor quizartinib. The compounds also inhibited the growth of leukemia in a mouse-disseminated AML model, and hence, the novel 3 H -pyrazolo[4,3- f ]quinoline-containing kinase inhibitors are potential lead compounds to develop into anticancer agents, especially for kinase-driven cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI